BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8940079)

  • 1. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells.
    Ho L; Fukuchi Ki; Younkin SG
    J Biol Chem; 1996 Nov; 271(48):30929-34. PubMed ID: 8940079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
    Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
    Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells.
    Lahiri DK; Farlow MR; Sambamurti K
    Brain Res Mol Brain Res; 1998 Nov; 62(2):131-40. PubMed ID: 9813282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amyloid beta-protein precursor of Alzheimer's disease is degraded extracellularly by a Kunitz protease inhibitor domain-sensitive trypsin-like serine protease in cultures of chick sympathetic neurons.
    Caswell MD; Mok SS; Henry A; Cappai R; Klug G; Beyreuther K; Masters CL; Small DH
    Eur J Biochem; 1999 Dec; 266(2):509-16. PubMed ID: 10561592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.
    Sambamurti K; Greig NH; Lahiri DK
    Neuromolecular Med; 2002; 1(1):1-31. PubMed ID: 12025813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells.
    Chen F; Yang DS; Petanceska S; Yang A; Tandon A; Yu G; Rozmahel R; Ghiso J; Nishimura M; Zhang DM; Kawarai T; Levesque G; Mills J; Levesque L; Song YQ; Rogaeva E; Westaway D; Mount H; Gandy S; St George-Hyslop P; Fraser PE
    J Biol Chem; 2000 Nov; 275(47):36794-802. PubMed ID: 10962005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRP-mediated clearance of Abeta is inhibited by KPI-containing isoforms of APP.
    Moir RD; Tanzi RE
    Curr Alzheimer Res; 2005 Apr; 2(2):269-73. PubMed ID: 15974929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Alzheimer's Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides.
    Siegel G; Gerber H; Koch P; Bruestle O; Fraering PC; Rajendran L
    Cell Rep; 2017 Jun; 19(10):1967-1976. PubMed ID: 28591569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles.
    Hook VY; Toneff T; Aaron W; Yasothornsrikul S; Bundey R; Reisine T
    J Neurochem; 2002 Apr; 81(2):237-56. PubMed ID: 12064471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein.
    Sambamurti K; Sevlever D; Koothan T; Refolo LM; Pinnix I; Gandhi S; Onstead L; Younkin L; Prada CM; Yager D; Ohyagi Y; Eckman CB; Rosenberry TL; Younkin SG
    J Biol Chem; 1999 Sep; 274(38):26810-4. PubMed ID: 10480887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.
    Moir RD; Lynch T; Bush AI; Whyte S; Henry A; Portbury S; Multhaup G; Small DH; Tanzi RE; Beyreuther K; Masters CL
    J Biol Chem; 1998 Feb; 273(9):5013-9. PubMed ID: 9478949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: Abeta N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology.
    Tekirian TL
    J Alzheimers Dis; 2001 Apr; 3(2):241-248. PubMed ID: 12214065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages.
    Lefranc-Jullien S; Sunyach C; Checler F
    J Neurochem; 2006 May; 97(3):807-17. PubMed ID: 16524370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42.
    Buggia-Prevot V; Sevalle J; Rossner S; Checler F
    J Biol Chem; 2008 Apr; 283(15):10037-47. PubMed ID: 18263584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP.
    Skovronsky DM; Pijak DS; Doms RW; Lee VM
    Biochemistry; 2000 Feb; 39(4):810-7. PubMed ID: 10651647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition.
    Dobrowolska JA; Michener MS; Wu G; Patterson BW; Chott R; Ovod V; Pyatkivskyy Y; Wildsmith KR; Kasten T; Mathers P; Dancho M; Lennox C; Smith BE; Gilberto D; McLoughlin D; Holder DJ; Stamford AW; Yarasheski KE; Kennedy ME; Savage MJ; Bateman RJ
    J Neurosci; 2014 Jun; 34(24):8336-46. PubMed ID: 24920637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
    Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
    Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/ε.
    Cisse M; Braun U; Leitges M; Fisher A; Pages G; Checler F; Vincent B
    Mol Cell Neurosci; 2011 Jul; 47(3):223-32. PubMed ID: 21570469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.